Latest Conference Articles

AmerisourceBergen is celebrating Good Neighbor Pharmacy’s 2021 Pharmacy of the Year Award finalists.

Educating families to alleviate fear in pediatric populations regarding the flu vaccine will improve the vaccination rate and protect high-risk children. Due to the negative effects of the flu in children with diabetes, it is vital that at-risk youth be vaccinated.

Study results showed there was no significant correlation between blood glucose levels and mortality or the rate of stay in intensive care units of hospitals for sick patients with diabetes, pneumonia, and COVID-19.

Texas-based pharmacy is one of three nationwide up for the award.

Iowa-based pharmacy is one of three nationwide up for the award.

California-based pharmacy is one of three nationwide up for the award

At the virtual Scientific Sessions for the American Diabetes Association, Jennifer Sherr, MD, discussed the findings of a study of the Omnipod 5 automated insulin delivery system in very young children with type 1 diabetes.

An oral abstract presentation at the American Diabetes Association Virtual 81st Scientific Sessions highlighted a cardioprotective benefit of sodium-glucose co-transporter-2 inhibitors.

At the virtual Scientific Sessions for the American Diabetes Association, a study shows that metformin can improve adolescent type 1 diabetes.

A study presented during a poster session at the American Diabetes Association Virtual 81st Scientific Sessions evaluated performance, safety, and satisfaction of an extended-wear insulin infusion set in patients with type 1 diabetes.

A study from the 2021 ASCO Annual Meeting examined the effect that oral anticancer agent initiation may have on adherence rates in patients with multiple myeloma and chronic conditions.

A study from the 2021 ASCO Annual Meeting assessed the prevalence of oncology drug shortages and how they hinder care for patients with cancer.

A poster presentation at the 2021 ASCO Annual Meeting discussed survival trends among patients with chronic lymphocytic leukemia.

A community oncology practice implemented a team-based approach to utilizing biosimilars.

Results of the phase 3 OlympiA study evaluating olaparib as adjuvant therapy in high-risk early-stage breast cancer therapy were presented at the 2021 ASCO Annual Meeting.

A study highlighted at the 2021 ASCO Annual Meeting explored whether patients who received an influenza vaccine were at increased risk for immune-related adverse events from single-agent immune checkpoint inhibitors.

Results of the phase 3 RATIONALE 203 study were presented at the 2021 ASCO Annual Meeting.

Findings from the phase 3 RELATIVITY-047 trial were presented at the 2021 ASCO Annual Meeting.

In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.

A session from the 2021 PQA Annual Meeting highlighted the benefits of virtual outreach in advancing patient care amid the COVID-19 pandemic and beyond.

Individuals with prediabetes may be at increased risk of suffering an adverse cardiovascular event.

A session at the 2021 Pharmacy Quality Alliance Meeting explored the results of Walgreens’ recent initiatives focused on addressing social determinants of health.

The awards honor an individual and community pharmacy for innovative, pioneering practices.

A session held during the 2021 PQA Annual Meeting explored implications for shared decision-making interventions in value-based care.

A session held at the HOPA Annual Meeting 2021 discussed investigational cancer drugs in clinical trials.

Real-world data comparing erenumab with oral preventive medications was presented at the American Academy of Neurology’s 73rd Annual Meeting.

A session held at the HOPA Annual Meeting 2021 discussed best practices for optimizing opioid treatment in patients with cancer pain.

Research presented at Academy of Managed Care Pharmacy’s 2021 virtual conference evaluated tolerance and adherence to oral disease-modifying therapies for relapsing-remitting multiple sclerosis.